/
Login
Analysis Scores
Damodaran ?
52/100
Dalio Risk ?
60/100
Piotroski ?
4/9
Neutral
prev year gross profit data missing → margin comparison unavailable (C8)
Graham ?
$35.8
Pahalı
Active Metric?
3/4
Confidence?
74%
Valuation
Potential?
+30.0%
ROIC ?
10.5%
DCF Value ?
47.25
Debt Cycle?
Early Expansion
Data
Data ?
3242
2013-10-14 → 2026-09-03
Risk Analysis (VaR)
Düşük
252 days
Annual Volatility ?
%19.0
VaR 95% ?
%2.01
daily max loss
VaR 99% ?
%2.82
daily max loss
CVaR 95% ?
%2.54
expected loss (tail)
Max Drawdown ?
%15.9
02.03.2026 → 17.08.2026
Skewness ?
0.10
Parametrik%2.01
Historik%2.02
Cornish-Fisher%1.95
Return Distribution
Fundamental & Technical Analysis
TRAMA-99 Trend — Downtrend
Price (42.34), TRAMA-99 line's %8.9 below. Downtrend ongoing — technical outlook negative. Pressure may continue until TRAMA is broken above.
Price:: 42.34
TRAMA: 46.4995
Difference: %-8.9
Profitability
Net Profit Margin
%53.1
Net profit margin %53.1 — very strong. Compared to previous quarter -2.1 point decrease.
ROE – Özkaynak Getirisi (TTM)
%20.1
ROE %20.1 — high return on equity.
EBITDA Margin
%94.6
EBITDA margin %94.6 — operationally very efficient.
Gross Profit Margin
%96.7
Gross profit per revenue %96.7. Strong pricing power.
Free Cash Flow Margin (TTM)
%37.9
TTM Free Cash Flow is %37.9'i. Strong FCF generation — profit quality is high.
Valuation
P/E Ratio
12.7x
Sector: 32.3x
F/K 12.7x — sector median's (32.3x) %61 below. Attractive for value investing.
P/B Ratio
2.47x
Sector: 3.83x
PD/DD 2.47x — sector median's (3.83x) çok below. Defter değerine göre undervalued.
EV/EBITDA
12.2x
Sector: 17.3x
EV/EBITDA 12.2x — sector median (17.3x) in line.
Indebtedness
Current Ratio
9.43x
Current ratio 9.43x — current assets are 2x short-term liabilities. Very healthy liquidity.
Net Debt / EBITDA
5.0x
Net Borç/EBITDA 5.0x — excessive leverage. Fragile debt profile.
Debt / Equity
1.68x
Borç/Özkaynak 1.68x — high leverage. Sensitive to debt cycle changes.
Interest Coverage
4.3x
Interest coverage 4.3x — interest obligations comfortably covered.
Growth
Revenue Growth (YoY)
%+9.0
Revenue YoY %9.0 grew — positive but slow growth.
Net Profit Growth (YoY)
%+50.8
Net profit YoY %50.8 increased (2026/6) — extraordinary profit growth.
Score Explanations
Lothien Robustness
67/100
Good robustness (67/100). The company shows a generally balanced financial profile; some areas have room for improvement.
Strong
Potential
+30.0%
Plus %30.0 expected value (54.98) vs current price comparison. 3/4 valuation models give 'BUY' signal. Model confidence %74.
Components: P/B target: 68.80 | EV/EBITDA target: 59.66 | DCF target: 47.25
Damodaran Valuation
52/100
Moderate Damodaran score (52/100). ROIC (%10.5) – WACC (%7.2) farkı +3.3 baz puan. Value creation capacity limited.
Moderate
Dalio Risk Analysis
60/100
Moderate debt risk (60/100). Interest coverage ratio 4.3x — acceptable. Borç/EBITDA 5.0x — high debt burden.
Leverage: 62/100 | Debt Service: 90/100 | Quality: 92/100
ROIC – Sermaye Getirisi
%10.5
ROIC (%10.5) slightly exceeds cost of capital (3.3 puan) aşıyor.
WACC: %7.2
DCF Discounted Cash Flow
47.25
DCF (47.25) near current price (%+11.7) near — in fair value zone.
Current price: 42.30
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
4/9
Weak Piotroski (4/9). Many balance sheet quality criteria not met. Note: prev year gross profit data missing → margin comparison unavailable (C8)
Neutral
Graham Intrinsic Value
$35.8
Güncel fiyat Graham valuenin %15.4 üzerinde ($35.8) — Expensive by Graham.
Expensive
⚖️ Sector Comparison
P/E Ratio
12.7x
vs 32.3x
Sector mediannın %61 below — cheap
P/B Ratio
2.47x
vs 3.83x
Compared to sector %36 cheaper (by book value)
EV/EBITDA
12.2x
vs 17.3x
Compared to sector %29 lower EV/EBITDA
ROIC vs WACC
%10.5
vs %7.2 WACC
ROIC 3.3 baz puan exceeds cost of capital
Charts
Indicators
BB deviation
?
RSI thresholds
?
▲ içeriden alım ·
▼ içeriden satım ·
★ katalizör (haber-sezgisel) ·
■ 13D aktivist ·
■ 13G pasif
— SEC Form 4 ~2 gün gecikmeli, yalnız yönetici/direktör/%10+ sahip; katalizör = haber-sezgisel; 13D/G = %5+ pay bildirimi ~5 iş günü gecikmeli.
İçeriden Alım-Satım Akışı
Kim aldı, kim sattı, ne kadar
GLPI — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.